(1).
LEM domain containing protein 2 (LEMD2)
is a member of the group II LEM domain proteins, which contain w40 conserved amino acids representing the LEM domain, a domain discovered previously in other INM proteins (6) (7) (8) (9) . It is ubiquitously expressed in the INM of the NE with an increase during telophase and lower expression in the endoplasmic reticulum (10) (11) (12) (13) .
LEMD2 binds the deoxyribonucleic acid (DNA)-binding protein barrier to autointegration factor (BANF) mediated by the LEM domain and interacts with nuclear lamins by its N-terminal and transmembrane domains (14) . Complete disruption in mice causes embryonic lethality by embryonic day 11.5, leading to reduced sizes of most tissues. Neural and heart structures appeared to be less developed and/or Recently, a mutation in LEMD2 has been associated with juvenile cataract and a risk for sudden cardiac death in the Hutterite population (16) . The Hutterite population is a genetic isolate who originated in Europe in the 16th century and emigrated to the United States and Canada in the 1870s. They can be traced back to <100 founders and are divided into 3 branches: Dariusleut, Lehrerleut (L-leut), and Schmiedeleut (S-leut) (17, 18) .
In the present study, we clinically and genetically Heart tissue was embedded in paraffin, and 5-mm thick slices were deparaffinized and stained with hematoxylin and eosin, Masson's trichrome, and picro sirius red (1% sirius red in saturated aqueous picric acid) as previously described (23) . An Olympus Bx54 microscope equipped with an UPlanSApo 100x/1.4NA objective (Olympus, Tokyo, Japan) was used for imaging. Samples for the transmission electron microscopy were fixed, dehydrated,
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Abdelfatah et al. Table 1 ). The phenotype of bilateral juvenile cataract was reported previously in family 600 (16, 25, 26) ;
however, it became obvious that cardiac disease may also be associated with it after 2 individuals from the original publications died suddenly at the ages of 28 and 43 years (family 600, III-2 and II-16).
Eighteen additional individuals from both families with a history of bilateral juvenile cataract were identified. Those who were available for study underwent detailed cardiac investigations ( Table 1) . Although not assessed by a neuromuscular specialist, none of the homozygous carriers Abdelfatah et al.
Arrhythmic Cardiomyopathy Caused by LEMD2 Mutation 
Abdelfatah et al. All living individuals are homozygous mutation carriers of the LEMD2 mutation. *Autopsy report summary: Heart was not enlarged but showed area of scarring at left ventricular (LV) free wall. Microscopic findings: Extensive transmural scar with neovascularization. Myocytes at the edge of scar are hypertrophied. The fibrosis extends around the myocytes and appears to expand interstitial spaces from the endocardium to the epicardial surface. There was no gross or microscopic vascular disease as well as no acute inflammation (no myocarditis). †Corresponding individual described by Boone et al. (16) . 
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Arrhythmic Cardiomyopathy Caused by LEMD2 Mutation w60 genes (Supplemental Table 2 ). LEMD2 was the only gene containing a novel homozygous missense mutation c.38T>G; p.L13R (chr.6: 33,772.202), which was not found in the Genome Aggregation Database (21) . All individuals from both families with juvenile cataracts were found to be homozygous for the c.38T>G mutation, except 1 carrier, who we believe is pre-symptomatic at 13 years of age (family 290, III-6).
The p.L13R mutation is located in the LEM domain at a highly evolutionary conserved position (Figure 2A ).
Three-dimensional protein remodeling of the mutated protein showed that the amino acid residue substitution R13 leads to steric hindrance to form a proper three-dimensional structure ( Figure 2B ).
To determine the carrier frequency of the p.L13R showed an invagination of the nuclear membrane as well as condensed clumping of peripheral heterochromatin ( Figure 2D ). All observed nuclei in cardiac tissue demonstrated those abnormalities (n ¼ 100 nuclei examined). In patient fibroblast cells, the invagination of the nuclear membrane was also frequently noticed, but the peripheral chromatin was less condensed compared with the nuclei of the heart tissue. Abnormal fibroblast nuclei were detected in 80% of the nuclei (n ¼ 300) at P2 and were increased to 90% at P15. Only a few abnormal nuclei (w20%) at P2 and 30% at P15 were detected in 300 nuclei of the age-matched control ( Figure 2E ).
To investigate a potential mislocalization of mutant LEMD2, immunohistochemistry experiments
were conducted of affected cardiac tissue, affected fibroblasts, and in vitro cellular expression studies of recombinant wild-type and mutant LEMD2 proteins.
We detected LEMD2 at the expected localization at the nuclear membrane in cardiac tissue from patient 600, II-16 and fibroblasts from patient 600, II-18 by using a C-terminal LEMD2-specific antibody. There was no difference compared with the control subjects in either experiment. Furthermore, staining of cardiac tissue and fibroblast cells showed co-localization of both LMNA and LEMD2 in patients and control subjects ( Figures 3A and 3B, Supplemental Figure 1 ).
We measured the expression of LEMD2 and LMNA by Western blot analysis using whole protein lysates from fibroblasts; no significant difference was noted between the patient and control subjects ( Figure 3C ).
We subsequently introduced the c. 
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Arrhythmic Cardiomyopathy Caused by LEMD2 Mutation respectively. There is a significant increase of abnormal nuclei in the patient cells (Pat) compared with the control (Ctrl1); n ¼ 300 nuclei; ***p < 0.001.
Arrhythmic Cardiomyopathy Caused by LEMD2 Mutation Western blot analysis of eGFP-LEMD2 proteins after transfection into HEK293 cells. GAPDH was used for loading control. Quantification by densitometry (n ¼ 3) reveals no difference in the protein level between mutant (p.R13) and WT (p.L13) LEMD2. Un ¼ un-transfected; other abbreviations as in Figure 2 .
Arrhythmic Cardiomyopathy Caused by LEMD2 Mutation LEMD2 has been shown to be involved in DNA replication and mitosis. To understand the effects of mutant LEMD2 on cell cycle progression, we stained fibroblasts from the patient and 2 control subjects by using propidium iodide and examined cell cycle phase distribution. A larger portion of patient cells and the older age control cells were unable to progress from the G1 phase to the S phase and resulted in a prolonged G1 phase, which was even more significant at higher passage numbers. These data indicate that mutant LEMD2 may induce a G1 arrest ( Figure 4C ).
Furthermore, we examined levels of cell cycle regulatory protein (Aurora B), a well-established G2/M phase marker. Whole protein lysates from patient cells exhibited decreased levels of Aurora B expression compared with both control subjects, consistent with the result from the cell cycle experiment ( Figure 4D ).
The abnormal proliferation profile seen in mutant fibroblasts could be a consequence of the imbalance between proliferation and apoptosis. We therefore assessed increased apoptosis in patient tissue and fibroblasts. First, affected heart and liver tissue were stained with 5-bromo-2 0 -deoxyuridine 5 0 -triphosphate, and the number of brown apoptotic bodies was counted. No obvious apoptotic bodies were detected in the patient and 2 control tissues ( Figure 5A ). We used the same assay in the patient and control fibroblasts and measured broken DNA ends by using flow cytometry. No significant difference in the apoptotic signals between the patient and the 2 control subjects were detected ( Figure 5B ). Finally, we tested the expression of caspase 3 and annexin V in whole protein lysates from fibroblasts and found no difference between the patient and control cells ( Figure 5C ).
These data suggest that the mutation in LEMD2 does not affect the apoptotic pathway. Interestingly, the delayed enhancement by CMR imaging detected subepicardial, subendocardial, and at later stages transmural patchy fibrosis affecting mainly the inferior and inferolateral wall segments.
Although the LGE pattern was suggestive of an ischemic etiology, there was no evidence of obstructive coronary artery disease on cardiac computed tomography imaging or coronary angiography.
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